Table 4 |
|||||
|
CV events from 6 months following initiation of SPAA or CCB+statin in primary prevention patients |
|||||
|
Overall |
Adherent |
Non-Adherent |
SPAA |
CCB+Statin |
|
|
N= |
(19,447) |
(4,693) |
(14,754) |
(1,537) |
(17,910) |
|
|
|||||
|
12-month Event Rate |
|||||
|
Total Events (N) |
452 |
88 |
364 |
19 |
433 |
|
Total Person-Years |
19,447 |
4,693 |
14,754 |
1,537 |
17,910 |
|
Incidence Rate per 100 person-years |
2.32 |
1.88 |
2.47 |
1.24 |
2.42 |
|
Overall Event Rate |
|||||
|
Total Events (N) |
818 |
164 |
654 |
38 |
780 |
|
Total Person-Years |
38,074 |
9,139 |
28,935 |
2,734 |
35,340 |
|
Incidence Rate per 100 person-years |
2.15 |
1.79 |
2.26 |
1.39 |
2.21 |
|
|
|||||
|
Chapman et al. BMC Cardiovascular Disorders 2010 10:29 doi:10.1186/1471-2261-10-29 |
|||||
